Member Exclusive Interview

Dual functional delivery strategy for cancer immunotherapy: an interview with Zhuoya Wan

At ACS San Diego (25—29 August 2019; CA, USA), we spoke with Zhuoya Wan (University of Pittsburg, PA, USA) to learn more about her work into Indoximod, a promising therapeutic anti-cancer agent, and approaches to improve its formulation and delivery.

Go to the profile of RxNet
Oct 07, 2019

Please sign in or register for FREE

No comments yet.